Date: 2016-01-04
Type of information: Nomination
Compound:
Company: Evgen Pharma (UK)
Therapeutic area: Cancer - Oncology - Neurological diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 4, 2016, Evgen Pharma announced the appointment of Dr Hamina J Patel as Chief Medical Officer. Dr Patel is a pharmaceutical executive with more than 15 years’ industry experience, leading global cross
functional teams in the development and commercialisation of drugs primarily within the field of oncology.
Dr Patel was previously Director of Drug Development, Oncology, at Johnson and Johnson, where she
helped to build a broad and differentiated portfolio of indications for the cancer drug Velcade® and was
instrumental in the success of a new indication (the second-line treatment of mantle cell lymphoma)
based on a Phase II clinical study in more than 35 countries. She received numerous awards for her
contribution to the Oncology group at Johnson and Johnson, including a Standard of Leadership award.
In addition to her small molecule expertise, Dr Patel has worked extensively in the development of
biopharmaceuticals at Celltech and at Chugai. Dr Patel qualified as a physician in 1990 and worked for almost ten years in hospitals around the UK before moving into the pharmaceutical industry.
Financial terms:
Latest news:
